Acorah Software Products - Accounts Production 19.2.450 false true 30 November 2024 1 December 2023 false true No description of principal activity 1 December 2024 30 November 2025 30 November 2025 14506571 Dr Daniel Skehan iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14506571 2024-11-30 14506571 2025-11-30 14506571 2024-12-01 2025-11-30 14506571 frs-core:CurrentFinancialInstruments 2025-11-30 14506571 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 14506571 frs-bus:FilletedAccounts 2024-12-01 2025-11-30 14506571 frs-bus:Micro-entities 2024-12-01 2025-11-30 14506571 frs-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 14506571 frs-bus:Director1 2024-12-01 2025-11-30 14506571 2023-11-30 14506571 2024-11-30 14506571 2023-12-01 2024-11-30 14506571 frs-core:CurrentFinancialInstruments 2024-11-30
Registered number: 14506571
Skehan Therapy Limited
Financial Statements
For The Year Ended 30 November 2025
TaxAssist Accountants Enfield
Balance Sheet
Registered number: 14506571
2025 2024
as restated
£ £
Current assets 1,695 2,714
Creditors: Amounts Falling Due Within One Year (589 ) (1,247 )
NET CURRENT ASSETS 1,106 1,467
TOTAL ASSETS LESS CURRENT LIABILITIES 1,106 1,467
NET ASSETS 1,106 1,467
CAPITAL AND RESERVES 1,106 1,467

Notes

1. General Information
Skehan Therapy Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14506571 . The registered office is 21 Mansfield Hill, London, E4 7SS.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Daniel Skehan
Director
09/06/2026